Exicure, Inc. XCUR

Set alert

Price alert · XCUR

All alert types
1.02 USD +0.01 +0.99%

At close · Nov 2

1.06 +0.04 +3.92%

After hours · Nov 2, 4:00 PM ET

Bid
0.99 × 1
Ask
1.08 × 2
0.9701 Day range 1.06
0.875 52-week range 9.48
YTD
-81.18%
1 year
-76.82%
Open
1.03
Prev close
1.01
Mkt cap
6.68M
Vol
31.36K
Avg vol
45.46K
EPS
-1.31
P/E
0.00
Div yield
0.00%
More statistics
Low
0.9701
High
1.06
Forward P/E
-25.38
Beta
1.28
Short ratio
0.19
Inst. own
4.29%
Dividend
0.00
Ex-div date
Earnings
May 16, 2024
50-d avg
10.48
200-d avg
4.42
1y target
0.00

2Y chart

Chart tools
Interval

Signals (68)
NameDateAgo
MACD: Buy SignalNov 2, 202617 hours ago
MACD: Sell SignalOct 29, 20264 days ago
MACD: Buy SignalOct 22, 20261 week ago
MACD: Sell SignalOct 21, 20261 week ago
MACD: Buy SignalOct 13, 20262 weeks ago
MACD: Sell SignalSep 29, 20261 month ago
MACD: Buy SignalAug 17, 20262 months ago
MACD: Sell SignalAug 12, 20262 months ago
RSI: OversoldAug 12, 20262 months ago
MACD: Buy SignalAug 11, 20262 months ago
MACD: Sell SignalAug 7, 20262 months ago
RSI: OversoldAug 6, 20262 months ago
MACD: Buy SignalJul 20, 20263 months ago
RSI: OversoldJul 8, 20263 months ago
MACD: Sell SignalJun 29, 20264 months ago
MACD: Buy SignalJun 24, 20264 months ago
MACD: Sell SignalJun 16, 20264 months ago
RSI: OversoldJun 16, 20264 months ago
MACD: Buy SignalMay 28, 20265 months ago
RSI: OversoldMay 15, 20265 months ago

Newest 20 of 68.

Key statistics

Market cap
59.38M
Enterprise value
11.80M
Trailing P/E
0.00
Forward P/E
-25.38
PEG ratio
0.00
Price / sales
118.77
Price / book
11.15
EPS (TTM)
-2.02
Beta
1.28
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
500.00K
Revenue growth
0.00%
Free cash flow
-2.03M
Total cash
528.00K
Total debt
7.32M
Return on equity
-144.41%
Shares outstanding
3.04M
Short % of float
1.99%
50-day average
10.48
200-day average
4.42

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

May 16, 2024

Expected May 16, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
XCUR Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
XCUR Net income — quarterly -1.12M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
XCUR EPS — quarterly -0.18
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

XCUR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 13, 2024Jun 1, 20240.00-0.35——
Jun 17, 2024Mar 1, 20240.00-0.50——
Jun 6, 2024Dec 1, 20230.00-0.65——
May 16, 2024Sep 1, 20230.00———
Aug 11, 2023Jun 1, 20230.00-3.40——
Jul 14, 2023Mar 1, 20230.00-3.50——

Upgrades / downgrades

XCUR analyst upgrades and downgrades
DateFirmActionFromTo
Aug 16, 2022Chardan Capitalmain—Neutral

About Exicure, Inc.

Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on XCUR — it syncs with the Stock Master app.

Insider holders

XCUR insider holders
InsiderRelationLatest transactionDateShares held
CBI USA, INC.Beneficial Owner of more than 10% of a Class of SecurityPurchaseDec 14, 20224,218,300
DGP CO., LTD.Beneficial Owner of more than 10% of a Class of SecuritySaleFeb 28, 20240
FELTNER DOUGLAS EOfficerStock Award(Grant)Nov 14, 202115,000
GATES VENTURES, L.L.C.Beneficial Owner of more than 10% of a Class of SecuritySaleDec 20, 20215,064,700
GILJOHANN DAVID A.Chief Executive OfficerStock Award(Grant)Nov 14, 202138,666
MIRKIN CHAD ADirector and Beneficial Owner of more than 10% of a Class of SecuritySaleJun 11, 20200

Institution ownership

XCUR institution ownership
Holder% heldSharesValueReported
Carlyle Group Inc.2.16%56,3281.10MSep 29, 2024
HRT Financial LP0.56%14,480282.94KSep 29, 2024
Northwestern University0.40%10,430203.80KSep 29, 2024
UBS Group AG0.37%9,588187.35KSep 29, 2024
Tower Research Capital LLC (TRC)0.05%1,41427.63KSep 29, 2024
Morgan Stanley0.02%64512.60KSep 29, 2024

Fund ownership

XCUR fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.31%8,019156.69KSep 29, 2024
Fidelity Extended Market Index Fund0.16%4,16781.42KOct 30, 2024
Fidelity Series Total Market Index Fund0.06%1,52729.84KOct 30, 2024
Fidelity Total Market Index Fund0.03%89617.51KOct 30, 2024
Master Investment Portfolio-Diversified Equity Master Portfolio0.00%35683Sep 29, 2024